Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2017; Announces Dividend for the Six Months Ended September 30, 2017, Payable on December 1, 2017; Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2018
October 23, 2017
Share
Eiken Chemical Co., Ltd. announced consolidated earnings results for the six months ended September 30, 2017. For the six months, the company reported net sales of JPY 17,462 million against JPY 16,804 million a year ago. Operating income was JPY 2,215 million against JPY 2,325 million a year ago. Ordinary income was JPY 2,255 million against JPY 2,343 million a year ago. Net income attributable to shareholders of parent company was JPY 1,633 million against JPY 1,715 million a year ago. Diluted net income per was JPY 88.15 against JPY 92.67 a year ago. Profit before income taxes was JPY 2,249 million against JPY 2,322 million a year ago.
The company announced a dividend of JPY 25.00 per share for the six months ended September 30, 2017, compared with JPY 20.00 per share a year ago. The scheduled date of dividend payment is December 1, 2017.
The company expects to pay a year-end dividend of JPY 25.00 per share for the fiscal year ending March 2018, compared with JPY 30.00 per share for the fiscal year ended March 2017.
The company provided consolidated earnings guidance for the fiscal year ending March 31, 2018. For the full year, the company expects net sales of JPY 35,840 million, operating income of JPY 3,070 million, ordinary income of JPY 3,070 million, and net income attributable to shareholders of parent company of JPY 2,180 million or JPY 119.00 per share.
EIKEN CHEMICAL CO., LTD. is a Japan-based company principally engaged in the manufacture and sale of test drugs. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2017; Announces Dividend for the Six Months Ended September 30, 2017, Payable on December 1, 2017; Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2018